SLGL Sol-Gel Technologies, Ltd.: Price-to-Projected Revenue Ratio

Sol-Gel Technologies (SLGL) faces threats from low-cost alternatives and patent disputes. The company's expected P/S, as shown in this GURU.Markets chart, demonstrates a fundamental price gap, where the value 102.90 indicates the current magnitude. Growth is based on licensing agreements with distribution partners; however, royalty volatility and R&D expenses are creating financial pressure.

SLGL (sol-gel.com) Projected Price to Revenue history from 07/04/2022 to 11/13/2026

SLGL (Sol-Gel Technologies, Ltd.): analytical breakdowns and indicator data

- market price and analyst price targets:

Price Chart Sol-Gel Technologies Ltd.|SLGL - Average Forecast Price

- company stock capitalization data:

Market Value Sol-Gel Technologies, Ltd.|SLGL - Total Company Value

- book value of equity indicators:

Accounting Value per Share Sol-Gel Technologies|SLGL - Book Value of Business|Market Capitalization to Book Value Ratio sol-gel.com|SLGL - Company Balance Sheet Assets

- business debt structure and liquidity details:

- net income and valuation multiples indicators:

SLGL - Company Net Income|Projected Future Earnings Sol-Gel Technologies|SLGL - Price to Earnings Ratio|Forward P/E Multiple Sol-Gel|SLGL - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Sol-Gel Technologies, Ltd.|SLGL - Operating profit before amortization|Earnings per share for the last twelve months Sol-Gel Technologies|SLGL - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months sol-gel.com|SLGL - Earnings per share growth in current year|Net earnings per share growth forecast for next year Sol-Gel Technologies

- revenue and sales proceeds data:

SLGL - Company Total Revenue|Projected Sales Volume Sol-Gel Technologies Ltd.|SLGL - Price-to-Revenue Multiple|Forward P/S Multiple Sol-Gel Technologies, Ltd.

Summary company analytics:Sol-Gel Technologies Ltd. (SLGL)

Forward P/S assesses the market value of Sol-Gel Technologies (SLGL) relative to expected revenue, making it possible to identify trend reversal points and the efficiency of operational transformation during a crisis recovery. By analyzing the forward P/S indicator, an investor can evaluate the stability of the capitalization of Sol-Gel Technologies (SLGL), which is supported by steady royalties from patent protection and inertial demand for dermatological products featuring silica microencapsulation.

Key competitors

Price-to-Projected Revenue Ratio Krystal Biotech KRYS|Apogee Therapeutics Inc (APGE) - Market Cap to Future Revenue Ratio|ARQT - Price-to-Projected Revenue Ratio|VCEL: Price-to-Projected Revenue Ratio|ORKA (Oruka Therapeutics Inc) - Forward Price-to-Revenue Multiple|Projected Price to Revenue Sanara MedTech SMTI|DBVT (DBV Tech) - Forward P/S Multiple|SLSN - Projected Price to Revenue|Forward P/S Multiple DERM|FBRX - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Empro Group Inc EMPG|AXIL Brands Inc - Price-to-Projected Revenue Ratio|MDCX: Forward Price-to-Revenue Multiple|Forward Price to Sales VRCA (Verrica Pharmaceuticals)|HOTH (hoththerapeutics.com) - Forward Price-to-Revenue Multiple|BFRI: Price to Expected Revenue Ratio|VYNE (VYNE Therapeutics, Inc.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Sonoma Pharma SNOA|Forward P/S Multiple QNRX|Forward Price-to-Revenue Multiple Azitra Inc AZTR|Forward P/S Multiple DRMA (Dermata)|Forward Price to Sales ELAB|RVNC - Price-to-Projected Revenue Ratio